What is the address of NGUIMGO Docteur en Médecine?

The registered office of NGUIMGO Docteur en Médecine is located at Grand'Route 64, 4367 Crisnée.

Is NGUIMGO Docteur en Médecine still active?

Yes. According to the CBE (28 September 2026) NGUIMGO Docteur en Médecine is active, legal situation “Normale toestand”, started on 29 December 2004.

Is NGUIMGO Docteur en Médecine registered on Peppol?

Yes, NGUIMGO Docteur en Médecine is registered on the Peppol network with ID 0208:0870885893.

What is the enterprise number of NGUIMGO Docteur en Médecine?

The enterprise number of NGUIMGO Docteur en Médecine is BE0870885893.

When was NGUIMGO Docteur en Médecine founded?

NGUIMGO Docteur en Médecine was founded on 29 December 2004.

Who are the directors of NGUIMGO Docteur en Médecine?

According to the 2024 annual accounts, the directors of NGUIMGO Docteur en Médecine are: PASCAL NGUIMGO.

Is NGUIMGO Docteur en Médecine a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 December 2004; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did NGUIMGO Docteur en Médecine make in 2024?

NGUIMGO Docteur en Médecine posted a profit after taxes of € 61,327 in financial year 2024.

What is the revenue of NGUIMGO Docteur en Médecine?

As a small company, NGUIMGO Docteur en Médecine is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 189,189.

NGUIMGO Docteur en Médecine (Private Limited) - Crisnée

Dossier NGUIMGO Docteur en Médecine, printed on 28 September 2026 from databakkes.be/en/0870885893/nguimgo-docteur-en-medecine. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

NGUIMGO Docteur en Médecine from Crisnée, company number BE0870885893, closed financial year 2024 with a result of € 61,327 after tax. For that financial year NGUIMGO Docteur en Médecine recorded a gross margin of € 189,189 and equity of € 163,926. Compared with financial year 2023, the result moved from € 67,948 to € 61,327. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2025.

What it is worth Healthy

€ 163,926

▼ 15% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 61,327

▼ 10% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 73,548

▲ € 56,846 vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 90,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2024

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 5,318

▲ 149% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

€ 17,411

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 2,666

▼ 41% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 34,165

▲ 27% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 73,884 Gross margin 2021: € 73,884 First fiscal year in the series	€ 110,025 Gross margin 2022: € 110,025 ▲ 49% vs 2021 (€ 73,884) Favourable step	€ 148,010 Gross margin 2023: € 148,010 ▲ 35% vs 2022 (€ 110,025) Favourable step	€ 189,189 Gross margin 2024: € 189,189 ▲ 28% vs 2023 (€ 148,010) Favourable step	▲ 28%
Profit after taxes	€ -1,822 Profit after taxes 2021: € -1,822 First fiscal year in the series	€ 27,826 Profit after taxes 2022: € 27,826 ▲ € 29,648 vs 2021 (€ -1,822) Favourable step	€ 67,948 Profit after taxes 2023: € 67,948 ▲ 144% vs 2022 (€ 27,826) Favourable step	€ 61,327 Profit after taxes 2024: € 61,327 ▼ 10% vs 2023 (€ 67,948) Unfavourable step	▼ 10%
Equity	€ 96,825 Equity 2021: € 96,825 First fiscal year in the series	€ 124,651 Equity 2022: € 124,651 ▲ 29% vs 2021 (€ 96,825) Favourable step	€ 192,599 Equity 2023: € 192,599 ▲ 55% vs 2022 (€ 124,651) Favourable step	€ 163,926 Equity 2024: € 163,926 ▼ 15% vs 2023 (€ 192,599) Unfavourable step	▼ 15%
Total debts	€ 26,371 Total debts 2021: € 26,371 First fiscal year in the series	€ 23,478 Total debts 2022: € 23,478 ▼ 11% vs 2021 (€ 26,371) Favourable step	€ 31,472 Total debts 2023: € 31,472 ▲ 34% vs 2022 (€ 23,478) Unfavourable step	€ 144,243 Total debts 2024: € 144,243 ▲ € 112,771 vs 2023 (€ 31,472) Unfavourable step	▲ € 112,771
Cash	€ 14,074 Cash 2021: € 14,074 First fiscal year in the series	€ 11,548 Cash 2022: € 11,548 ▼ 18% vs 2021 (€ 14,074) Unfavourable step	€ 16,702 Cash 2023: € 16,702 ▲ 45% vs 2022 (€ 11,548) Favourable step	€ 73,548 Cash 2024: € 73,548 ▲ € 56,846 vs 2023 (€ 16,702) Favourable step	▲ € 56,846
Retained profit	€ 84,225 Retained profit 2021: € 84,225 First fiscal year in the series	€ 112,051 Retained profit 2022: € 112,051 ▲ 33% vs 2021 (€ 84,225) Favourable step	€ 179,999 Retained profit 2023: € 179,999 ▲ 61% vs 2022 (€ 112,051) Favourable step	€ 151,326 Retained profit 2024: € 151,326 ▼ 16% vs 2023 (€ 179,999) Unfavourable step	▼ 16%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 0 Dividend 2022: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 90,000 Dividend 2024: € 90,000 Unchanged (€ 0) Unchanged
Bank debt	€ 24,877 Bank debt 2021: € 24,877 First fiscal year in the series	€ 13,197 Bank debt 2022: € 13,197 ▼ 47% vs 2021 (€ 24,877) Favourable step	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 13,197) Favourable step	€ 17,411 Bank debt 2024: € 17,411 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 123,196 Balance sheet total 2021: € 123,196 First fiscal year in the series	€ 148,128 Balance sheet total 2022: € 148,128 ▲ 20% vs 2021 (€ 123,196) Unchanged	€ 224,071 Balance sheet total 2023: € 224,071 ▲ 51% vs 2022 (€ 148,128) Unchanged	€ 308,168 Balance sheet total 2024: € 308,168 ▲ 38% vs 2023 (€ 224,071) Unchanged	▲ 38%

Key figures of NGUIMGO Docteur en Médecine, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to NGUIMGO Docteur en Médecine?

What happened at NGUIMGO Docteur en Médecine in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2025 New annual accounts for financial year 2024: profit of € 61,327 (▼ 10% vs 2023). filed late Source: NBB ↗
2011 PASCAL NGUIMGO became a director. NBB
Dec 29, 2004 Start of the company according to the CBE. KBO

In short

From € 1,822 loss in 2021 to € 61,327 profit in 2024.

Paid € 59,307 in corporate taxes since 2021.

Best year ever: 2023, with € 67,948 profit.

Paid out € 90,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at NGUIMGO Docteur en Médecine? We notify you, reason included.

Follow NGUIMGO Docteur en Médecine

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

PASCAL NGUIMGO

NGUIMGO Docteur en Médecine

Behind NGUIMGO Docteur en Médecine is PASCAL NGUIMGO.

See the full network in the app

Directors

According to the 2024 annual accounts

PASCAL NGUIMGO

Director

since 2011

Establishments

Establishment units

Physical locations of this company

Registered office

Grand'Route 64

4367 Crisnée

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0870.885.893
VAT number: BE 0870.885.893
Registered office: Grand'Route 64, 4367 Crisnée
Names & denominations: NGUIMGO Docteur en Médecine
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 December 2004
Peppol: Active · Active since 17 Sept 2026

View on CBE Public ↗ Annual accounts (NBB) ↗